TABLE 2.
Erythrocytic biomarkers | Diagnosis | HAMA (N = 70) | HAMD (N = 70) | MDS-UPDRS III (N = 74) | H&Y (N = 90) | MMSE (N = 67) | MoCA (N = 67) | |
Total α-syn | PD | r | −0.292 | −0.182 | 0.455 | 0.170 | −0.134 | −0.153 |
p | 0.016 | 0.140 | <0.001 | 0.113 | 0.291 | 0.227 | ||
Oligomeric α-syn | PD | r | 0.057 | 0.131 | 0.107 | −0.106 | −0.147 | −0.152 |
p | 0.649 | 0.291 | 0.368 | 0.327 | 0.248 | 0.229 |
Partial correlation analysis with the controlling of age and sex was used to assess the r and p -values between erythrocytic biomarkers and clinical characteristics.
PD, Parkinson’s disease; α-syn, α-synuclein; HAMA, Hamilton Anxiety Rating Scale; HAMD, 17-item Hamilton Depression Rating Scale; MDS-UPDRS III, Movement Disorder Society sponsored Unified Parkinson’s Disease Rating Scale Part-III; H&Y, Hoehn & and Yahr scale; MMSE, Mini-mental State Examination; MoCA, Montreal Cognitive Assessment.
All significant p-values are highlighted by bold characters.